Cornerstone Planning Group’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9K | Hold |
164
| – | – | ﹤0.01% | 537 |
|
|
2025
Q1 | $9.89K | Hold |
164
| – | – | ﹤0.01% | 572 |
|
|
2024
Q4 | $11.4K | Hold |
164
| – | – | ﹤0.01% | 399 |
|
|
2024
Q3 | $11.3K | Sell |
164
-1
| -0.6% | -$69 | ﹤0.01% | 394 |
|
|
2024
Q2 | $10.9K | Buy |
165
+1
| +0.6% | +$66 | ﹤0.01% | 422 |
|
|
2024
Q1 | $10.5K | Hold |
164
| – | – | ﹤0.01% | 399 |
|
|
2023
Q4 | $10.8K | Hold |
164
| – | – | ﹤0.01% | 415 |
|
|
2023
Q3 | $9.35K | Buy |
+164
| New | +$9.35K | ﹤0.01% | 438 |
|